Cargando…
Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury
Ischemic stroke is the second cause of mortality and the first cause of long-term disability constituting a serious socioeconomic burden worldwide. Approved treatments include thrombectomy and rtPA intravenous administration, which, despite their efficacy in some cases, are not suitable for a great...
Autores principales: | Hernández, Ivó H., Villa-González, Mario, Martín, Gerardo, Soto, Manuel, Pérez-Álvarez, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305833/ https://www.ncbi.nlm.nih.gov/pubmed/34208834 http://dx.doi.org/10.3390/cells10071639 |
Ejemplares similares
-
Dysregulation of mTOR Signaling after Brain Ischemia
por: Villa-González, Mario, et al.
Publicado: (2022) -
Innovative Pharmacological/Therapeutic Approaches against Hepatic Ischemia/Reperfusion Injury
por: Vairetti, Mariapia, et al.
Publicado: (2015) -
Glial cells in the center of future ischemic stroke treatments
por: Hernández, Ivó H., et al.
Publicado: (2022) -
Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches
por: Sánchez-Hernández, César Daniel, et al.
Publicado: (2020) -
Therapeutic strategies for ischemia reperfusion injury in emergency medicine
por: Naito, Hiromichi, et al.
Publicado: (2020)